si-VDAC1 treatment of several tumor types induces metabolic rewiring of the malignant phenotype of cancer metabolism, resulting in a reversal of oncogenic properties that include reduced tumor growth, invasivity, stemness, epithelial–mesenchymal transition (EMT), and angiogenesis [16]. Here, VDAC1 is linked to cancer.